Qingdao
China
Shandong First Medical University
SphK inhibitors, S1P, virtual screening, structure-based drug design, structure activity relationship, anti-prostatic cancer
SphKs inhibitors, S1P, virtual screening, structure-based drug design, structure-activity relationship, anti-prostatic cancer
Sphingosine Kinase Inhibitors, K145, anticancer, Structure-activity relationship
Sphingosine kinase inhibitors, Computer-aided drug design, S1P, structure-activity relationship